Open an account

Guardian Pharmacy Services

GRDN · NYSE

$41.87+$1.73 (+4.31%)TodayMarket closed ·
Prev close $40.14

About GRDN

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,600 full-time employees. The company went IPO on 2024-09-26. The firm provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. The company offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. The company organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. The company offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

Employees
3,600
Headquarters
Atlanta, Georgia
Listed
Sep 26, 2024
Sector
Health Care
Industry
Health Care Providers & Services
Website
guardianpharmacy.com

GRDN key statistics

Market cap
2.65B
Price-earnings ratio
38.82
Dividend yield
—
Average volume
469.47K
Volume
591.41K
Open price
$40.39
High today
$42.26
Low today
$39.67
52 Week high
$48.33
52 Week low
$25.02

Guardian Pharmacy Services (GRDN) at a glance

Guardian Pharmacy Services (GRDN) last traded at $41.87, with a market cap of 2.65B and a price-to-earnings ratio of 38.82.

Today the stock has traded between $39.67 and $42.26. The current price is 5.6% above the day's low and 0.9% below its high.

Volume so far is 591.41K shares, above the average of 469.47K shares a day.

Over the past year Guardian Pharmacy Services has ranged from $25.02 to $48.33, and now sits 72% of the way up that range.

Guardian Pharmacy Services met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.34 per share against an estimate of $0.2795.

The average analyst price target is $50.85, 21.5% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 6 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 9 analystsAvg $50.85
Low
$47.47
Now
$41.87
High
$54.60

GRDN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 21.3% on average.

  1. Q3 FY24: reported -$2.00 per share against an estimate of $0.1938
  2. Q4 FY24: reported $0.19 per share against an estimate of $0.1683
  3. Q1 FY25: reported $0.15 per share against an estimate of $0.1836
  4. Q2 FY25: reported $0.14 per share against an estimate of $0.1581
  5. Q3 FY25: reported $0.15 per share against an estimate of $0.1734
  6. Q4 FY25: reported $0.33 per share against an estimate of $0.255
  7. Q1 FY26: reported $0.21 per share against an estimate of $0.2363
  8. Q2 FY26: reported $0.34 per share against an estimate of $0.2795

GRDN news

  • Press releaseBusiness Wire

    Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy

  • Press releaseBusiness Wire

    Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference

  • Press releaseBusiness Wire

    Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

  • Press releaseBusiness Wire

    Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

  • Press releaseBusiness Wire

    Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

  • Press releaseBusiness Wire

    Guardian Pharmacy Services, Inc. Announces Leadership Transitions

  • Press releaseBusiness Wire

    Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

Similar companies

Companies in the same industry as Guardian Pharmacy Services

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.